SCHEMBL25246748

SCHEMBL25246748

C1CCC([C]2CCO2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25356176 0.97 ALDH1A1 (0.32)
SCHEMBL25256691 0.94
SCHEMBL25245675 0.88
SCHEMBL6234011 0.83
SCHEMBL6322553 0.81
SCHEMBL25246055 0.81 CA1 (0.39)
SCHEMBL19181540 0.79 CA1 (0.37)
SCHEMBL156244 0.79
SCHEMBL7462821 0.79
SCHEMBL18669240 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116947877-A Benzimidazole derivative and application thereof in medicine 四川海思科制药有限公司 2023-10-27 CN claimed
WO-2023151697-A1 METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE 四川海思科制药有限公司 2023-08-17 WO claimed
WO-2023109902-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF IN MEDICINE 海思科医药集团股份有限公司 2023-06-22 WO claimed
WO-2023151697-A1 METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE 四川海思科制药有限公司 2023-08-17 WO disclosed
WO-2023109902-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF IN MEDICINE 海思科医药集团股份有限公司 2023-06-22 WO disclosed